(Reuters) — U.S. immunotherapy company Inovio Pharmaceuticals Inc (INO.O) said on Wednesday its experimental vaccine to prevent coronavirus infection produced protective antibodies and immune system responses in mice and guinea pigs.
(Reuters) — U.S. immunotherapy company Inovio Pharmaceuticals Inc (INO.O) said on Wednesday its experimental vaccine to prevent coronavirus infection produced protective antibodies and immune system responses in mice and guinea pigs.
Comments are closed.